Shares of NuVasive jump on Wall Street today after the medical device company reports earnings ahead of analysts' expectations.
NuVasive Inc. (NSDQ:NUVA) shares gained nearly 8% today after the medical device company reported beating expectations with its 4th-quarter earnings as it swung to black ink.
Endo Health Solutions says the attorneys general from several states including California are investigating its pelvic mesh products; 4th-quarter earnings beat expectations, but Endo's outlook disappoints Wall Street.
Endo Health Solutions (NSDQ:ENDP) said its pelvic mesh products are under investigation by the attorneys general from several states including California.
Diabetes devices maker Insulet posts a stellar quarter that beats Wall Street's expectations and notes a pending Massachusetts Attorney General inquiry.
Massachusetts-based Insulet (NSDQ:PODD) got some Wall Street love today after posing a significant bump in sales for its 4th quarter and the full year of 2013.
HeartWare shares come under pressure after the medical device company reports higher-than-expected losses for the 4th quarter and 2013.
Investors punished HeartWare International (NSDQ:HTWR) today for missing expectations with its 4th-quarter and full-year results, paring some 3% from HTWR shares.
NxStage Medical beats expectations with its 4th-quarter and 2013 results, but investors send shares down anyway.
NxStage Medical (NSDQ:NXTM) shares rose today after the medical device company said it just beat estimates with its results for the 4th quarter and last year.
LeMaitre Vascular says it plans to lay off about 10% of its workforce, or roughly 30 workers, despite posting record sales during the 4th quarter.
LeMaitre Vascular (NSDQ:LMAT) said it plans to lay off about 10% of its workforce, or about 30 employees, even as it comes off of a record sales performance during the 4th quarter.
Officials at Volcano discuss the company's Q4 2013 earnings. The company reported losses of $20.5 million, or 38¢ per share, on sales of $103.3 million for the 3 months ended December 31, for swing to losses on sales growth of 0.8%.